DeanSheppardMD

Pulmonology • San Francisco, CA

Pleural Disease

Professor, Medicine, UCSF School of Medicine

Join to view full profile

Dr. Sheppard is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Sheppard's full profile

Already have an account?

Office
CVRI-MC 31181, Room 252R
555 Mission Bay Blvd South
San Francisco, CA 94158
Phone+1 415-514-4269

Fax+1 415-476-2283

Education & Training

University of WashingtonResidency, Internal Medicine, 1975 - 1978
Stony Brook University Health Sciences Center School of MedicineClass of 1975

Certifications & Licensure

CA State Medical License 1978 - 2024
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Pulmonary Disease

Awards, Honors, & Recognition

Association of American Physicians 1995
Elected Member The American Society for Clinical Investigation, 1993
Whos Who in Medicine and Healthcare Marquis Whos Who

Publications & Presentations

PubMed

Impaired myofibroblast proliferation is a central feature of pathologic post-natal alveolar simplification.
Imran S Khan, Christopher Molina, Xin Ren, Vincent C Auyeung, Max Cohen
Elife. 2024-12-11
IL-13 and IL-17A activate β1 integrin through an NF-kB/Rho kinase/PIP5K1γ pathway to enhance force transmission in airway smooth muscle.
Uyen Ngo, Ying Shi, Prescott Woodruff, Kevan Shokat, William DeGrado
Proceedings of the National Academy of Sciences of the United States of America. 2024-08-20
10 citations
Alveolar fibroblast lineage orchestrates lung inflammation and fibrosis.
Tatsuya Tsukui, Paul J Wolters, Dean Sheppard
Nature. 2024-07-01

Press Mentions

3 Researchers Named 2021 Fellows of American Association for the Advancement of ScienceJanuary 26th, 2022
With One Rival down, Novartis-Partnered Biotech Scores $100M Round to Fund Mid-Stage Trials of Fibrosis DrugMarch 3rd, 2020
Devastating Disease of the Lung Is a New Research Gift’s FocusJuly 16th, 2018
Join now to see all